EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C26H54NO7P |
| Net Charge | 0 |
| Average Mass | 523.692 |
| Monoisotopic Mass | 523.36379 |
| SMILES | CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O |
| InChI | InChI=1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1 |
| InChIKey | HVAUUPRFYPCOCA-AREMUKBSSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Applications: | antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. bronchoconstrictor agent A drug which causes a narrowing of the lumen of a bronchus or bronchiole. hematologic agent Drug that acts on blood and blood-forming organs and those that affect the hemostatic system. vasodilator agent A drug used to cause dilation of the blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role antihypertensive agent (CHEBI:35674) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role bronchoconstrictor agent (CHEBI:50141) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role hematologic agent (CHEBI:50248) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role vasodilator agent (CHEBI:35620) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) has role β-adrenergic antagonist (CHEBI:35530) |
| 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (CHEBI:44811) is a 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine (CHEBI:36707) |
| IUPAC Name |
|---|
| (2R)-2-acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate |
| Synonyms | Source |
|---|---|
| 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine | LIPID MAPS |
| 1-O-hexadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine | ChemIDplus |
| 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosophocholine | ChemIDplus |
| platelet-activating factor C16 | ChemIDplus |
| 1-O-hexadecyl-platelet-activating factor | ChemIDplus |
| 1-O-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine | ChemIDplus |
| UniProt Name | Source |
|---|---|
| 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine | UniProt |
| Manual Xrefs | Databases |
|---|---|
| PFS | PDBeChem |
| LMGP01020046 | LIPID MAPS |
| Platelet-activating_factor | Wikipedia |
| DB02261 | DrugBank |
| Registry Numbers | Sources |
|---|---|
| Reaxys:3574588 | Reaxys |
| CAS:74389-68-7 | ChemIDplus |
| Citations |
|---|